Adenosine deaminase in malaria infection: effect of 2'-deoxycoformycin in vivo.
D000243:Adenosine Deaminase / Q000097:blood*; D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D003070:Coformycin / Q000031:analogs & derivatives / Q000627:therapeutic use*; D004912:Erythrocytes / Q000201:enzymology*; D008253:Macaca mulatta; D008288:Malaria / Q000188:drug therapy / Q000201:enzymology*; D008297:Male; D009700:Nucleoside Deaminases / Q000097:blood*; D015649:Pentostatin; D010961:Plasmodium / Q000472:pathogenicity; D012263:Ribonucleosides / Q000627:therapeutic use*
D058892:Adenosine Deaminase Inhibitors; D012263:Ribonucleosides; D003070:Coformycin; D015649:Pentostatin; D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase